Viatris Inc.
VTRS · NASDAQ · USD
$17.64
+0.20 1.15%todayNot financial advice.
- Open
- 17.36
- Day range
- 17.19 - 17.76
- 52-week range
- 9.73 - 18.43
- Volume
- 8.83M
- Market cap
- 20.26B
- P/E ratio
- —
- EPS
- -0.35
- Dividend yield
- 2.72%
- Beta
- 0.62
Performance
W
+0.63%
1M
+5.50%
3M
+7.96%
6M
+28.38%
YTD
+41.12%
Y
+76.22%
5Y
+28.85%
All
+35.2K%
In the news
Oct 10
Major M&A Deals Highlight Weekly Sector Activity Across Tech, Healthcare, and Energy
A wave of multi-billion dollar acquisition and merger agreements reshaped healthcare, tech, and energy markets this week.
Mergers
Oct 10
Viatris and GE HealthCare Lead Week of U.S. Healthcare M&A and Licensing Deals
Viatris agrees to acquire Pacira BioSciences for $1.65 billion, while GE HealthCare buys Sofie Biosciences to expand imaging infrastructure.
Mergers
Oct 9
Viatris to Acquire Pacira BioSciences for 1.65 Billion in Cash
Viatris has agreed to buy Pacira BioSciences for 1.65 billion dollars in cash to expand its non-opioid pain management portfolio.
Mergers
Oct 8
Pacira and Haemonetics Shares Surge on Acquisition Deal and Expanded Partnership
Pacira BioSciences surges on a $1.65 billion buyout by Viatris, while Haemonetics climbs after expanding its plasma collection partnership.
Mergers
Oct 8
Viatris to Acquire Pacira BioSciences for $1.65 Billion to Expand Non-Opioid Pain Portfolio
Viatris is buying Pacira BioSciences for $1.65 billion to expand its non-opioid pain treatment portfolio and boost its innovative medicines business.
Mergers
Oct 8
Viatris to Acquire Pacira BioSciences in $36.50 Per Share Cash Deal
Viatris has agreed to acquire Pacira BioSciences for $36.50 per share in cash to expand its specialty pharmaceuticals business and build synergies.
Mergers
Oct 8
Viatris to Acquire Pacira BioSciences in $1.65 Billion Cash Deal
Viatris has agreed to buy Pacira BioSciences for $36.50 per share in cash in a deal valued at $1.65 billion, expected to close by the end of 2026.
Mergers
Oct 8
Viatris Agrees to Acquire Pacira BioSciences to Expand Non-Opioid Pain Therapies
Viatris has agreed to acquire Pacira BioSciences to expand its innovative medicines portfolio and grow its presence in non-opioid pain treatments.
Mergers
Embed on your site
Embed docsAdd a live price card or a chart to any page. Free, no sign-up; cards refresh every minute and link back here.
<iframe src="https://stocks.freetheai.org/embed/NASDAQ-VTRS" width="340" height="170" style="border:0;max-width:100%" loading="lazy" title="Viatris Inc. (VTRS) - FreeTheAI Stocks"></iframe>
<p style="font-size:12px"><a href="https://stocks.freetheai.org/symbols/NASDAQ-VTRS">VTRS stock price</a> by FreeTheAI Stocks</p>